The expression of vascular endothelial growth factor-C correlates with lymphatic microvessel density and lymph node metastasis in prostate carcinoma: An immunohistochemical study

Urology Annals

Volumn 6, Issue 3, 2014, Pages 224-230

  Kostis, Gyftopoulos ^a   Ioannis, Lilis ^a   Helen, Kourea ^a   Helen, Papadaki ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Immunohistochemistry; lymphangiogenesis; prostate adenocarcinoma; vascular endothelial growth factor C; vessel density

Indexed keywords

LYMPHATIC VESSEL ENDOTHELIAL HYALURONAN RECEPTOR 1; PODOPLANIN; TUMOR MARKER; UNCLASSIFIED DRUG; VASCULOTROPIN C;

ADULT; AGED; ARTICLE; CAPILLARY DENSITY; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPHANGIOGENESIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CARCINOMA; PROTEIN EXPRESSION; TUMOR INVASION;

EID: 84902492132     PISSN: 09747796     EISSN: 09747834     Source Type: Journal    
DOI: 10.4103/0974-7796.134275     Document Type: Article

References (28)

1. Hoffman RM. Randomized trial results did not resolve controversies surrounding prostate cancer screening. Curr Opin Urol 2010;20:189-93.
2. Flanigan RC, McKay TC, Olson M, Shankey TV, Pyle J, Waters WB. Limited efficacy of preoperative computed tomographic scanning for the evaluation of lymph node metastasis in patients before radical prostatectomy. Urology 1996;48:428-32.
3. Burkhard FC, Studer UE. Regional lymph node staging in prostate cancer: Prognostic and therapeutic implications. Surg Oncol 2009;18:213-8.
4. Gou HF, Chen XC, Zhu J, Jiang M, Yang Y, Cao D, et al. Expressions of COX-2 and VEGF-C in gastric cancer: Correlations with lymphangiogenesis and prognostic implications. J Exp Clin Cancer Res 2011;30:14.
5. Botting SK, Fouad H, Elwell K, Rampy BA, Salama SA, Freeman DH, et al. Prognostic significance of peritumoral lymphatic vessel density and vascular endothelial growth factor receptor 3 in invasive squamous cell cervical cancer. Transl Oncol 2010;3:170-5.
6. Trojan L, Rensch F, Voss M, Grobholz R, Weiss C, Jackson DG, et al. The role of the lymphatic system and its specific growth factor, vascular endothelial growth factor C, for lymphogenic metastasis in prostate cancer. BJU Int 2006;98:903-6.
7. Jain RK, Padera TP. Prevention and treatment of lymphatic metastasis by antilymphangiogenic therapy. J Natl Cancer Inst 2002;94:785-7.
8. Zeng Y, Opeskin K, Horvath LG, Sutherland RL, Williams ED. Lymphatic vessel density and lymph node metastasis in prostate cancer. Prostate 2005;65:222-30.
9. Sands ME, Pollack A, Zagars GK. Influence of radiotherapy on node-positive prostate cancer treated with androgen ablation. Int J Radiat Oncol Biol Phys 1995;31:13-9.
10. Montironi R, Mazzucchelli R, Scarpelli M, Lopez-Beltran A, Mikuz G. Prostate carcinoma I: Prognostic factors in radical prostatectomy specimens and pelvic lymph nodes. BJU Int 2006;97:485-91.
11. Lee SK, Cho EY, Kim WW, Kim SH, Hur SM, Kim S, et al. The prediction of lymph node metastasis in ductal carcinoma in situ with microinvasion by assessing lymphangiogenesis. J Surg Oncol 2010;102:225-9.
12. Kuroda K, Horiguchi A, Asano T, Asano T, Hayakawa M. Prediction of lymphatic invasion by peritumoral lymphatic vessel density in prostate biopsy cores. Prostate 2008;68:1057-63.
13. Roma AA, Magi-Galluzzi C, Kral MA, Jin TT, Klein EA, Zhou M. Peritumoral lymphatic invasion is associated with regional lymph node metastases in prostate adenocarcinoma. Mod Pathol 2006;19:392-8.
14. Soh S, Ishii T, Sato E, Akishima Y, Ito K, Baba S. Topographic distribution of lymphatic vessels in the normal human prostate. Prostate 2005;63:330-5.
15. Nibbs RJ, Kriehuber E, Ponath PD, Parent D, Qin S, Campbell JD, et al. The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors. Am J Pathol 2001;158:867-77.
16. Johnson LA, Prevo R, Clasper S, Jackson DG. Inflammation-induced uptake and degradation of the lymphatic endothelial hyaluronan receptor LYVE-1. J Biol Chem 2007;282:33671-80.
17. Kim H, Dumont DJ. Molecular mechanisms in lymphangiogenesis: Model systems and implications in human disease. Clin Genet 2003;64:282-92.
18. Aishima S, Nishihara Y, Iguchi T, Taguchi K, Taketomi A, Maehara Y.Lymphatic spread is related to VEGF-C expression and D2-40-positive myofibroblasts in intrahepatic cholangiocarcinoma. Mod Pathol 2008;21:256-64.
19. Baydar DE, Baseskioglu B, Ozen H, Geyik PO. Prognostic significance of lymphovascular invasion in clinically localized prostate cancer after radical prostatectomy. Sci World J 2008;8:303-12.
20. Wong SY, Haack H, Crowley D, Barry M, Bronson RT, Hynes RO. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis. Cancer Res 2005;65:9789-98.
21. Isaka N, Padera TP, Hagendoorn J. Peritumor lymphatics induced by vascular endothelial growth factor-C exhibit abnormal function. Cancer Res 2004;64:4400-4.
22. Lohela M, Saaristo A, Veikkola T. Lymphangiogenic growth factors, receptors and therapies. Thromb Haemost 2003;90:167-84.
23. Hoshida T, Isaka N, Hagendoorn J, DI tomaso e, Chen YL, Pytowski B, et al. Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: Therapeutic implications. Cancer Res 2006;66:8065-75.
24. Lucia MS, Torkko KC. Inflammation as a target for prostate cancer chemoprevention: Pathological and laboratory rationale. J Urol 2004;171:S30-4.
25. Kärjä V, Aaltomaa S, Lipponen P, Isotalo T, Talja M, Mokka R. Tumour-infiltrating lymphocytes: A prognostic factor of PSA-free survival in patients with local prostate carcinoma treated by radical prostatectomy. Anticancer Res 2005;25:4435-8.
26. Saharinen P, Tammela T, Karkkainen MJ, Alitalo K. Lymphatic vasculature: Development, molecular regulation and role in tumor metastasis and inflammation. Trends Immunol 2004;25:387-95.
27. Hamrah P, Chen L, Zhang Q, Dana MR. Novel expression of vascular endothelial growth factor receptor (VEGFR)-3 and VEGF-C on corneal dendritic cells. Am J Pathol 2003;163:57-68.
28. Epstein JI, Allsbrook WC Jr, Amin MB, Egevad LL. Update on the Gleason grading system for prostate cancer: Results of an international consensus conference of urologic pathologists. Adv Anat Pathol 2006;13:57-9.